Search

everythinglearnresearchcommunity

for

Search:↓

PCOS causes infertility mainly due to hormonal imbalances, insulin resistance, and chronic inflammation.

Elagolix did not effectively treat polycystic ovary syndrome.

Obesity leads to physical, metabolic, reproductive issues, higher healthcare costs, and mental health problems.

Early detection, consistent management, and lifestyle changes are crucial for managing HAIR-AN syndrome effectively.

Most women with PCOS have high levels of male hormones, and free testosterone is the best marker for this.

Finasteride reduces hair growth better, but spironolactone has more side effects.

All three treatments reduce hirsutism, but spironolactone works best long-term.

Finasteride effectively treats hirsutism in women, but more research needed for long-term results.

Some women with PCOS have CYP21 mutations and IRS1 variants, but these genetic factors are not major contributors to PCOS.

Finasteride and flutamide both reduce hair growth, but finasteride has fewer side effects.

Teens with PCOS and a mom with PCOS have higher insulin resistance and lower adiponectin levels, which could signal early metabolic problems.

People with hair loss may have different levels of certain hormones due to changes in hormone processing.

The N363S gene variant does not cause higher adrenal androgen levels in women with polycystic ovary syndrome.

Changing the diagnosis criteria for PCOS might miss women at risk for related health issues.

Some patients with high prolactin levels don't show symptoms because they have a form of the hormone that's less active.

PCOS involves hormonal and metabolic issues, increasing risks for diabetes and heart disease, and requires lifestyle changes and medication for management.

Exposure to fatty acids significantly increased androgen levels in female dogs, suggesting a link to conditions like insulin resistance and PCOS.

Female relatives of PCOS patients have a higher chance of showing PCOS symptoms.

The 2003 consensus updated PCOS diagnosis criteria and highlighted increased risks of diabetes and heart disease for those affected.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

Testing basal 17-HP levels is a good way to screen for nonclassic adrenal hyperplasia in women with high androgen levels.

Flutamide may slightly improve hair loss in women, but finasteride does not work.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

Finasteride effectively reduces hair growth in women with idiopathic hirsutism, but requires careful contraception during treatment.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

Eating cream can increase ovarian androgen production in women with Polycystic Ovary Syndrome, which is not related to obesity.

Finasteride helps induce ovulation in nonresponder PCOS women.

African American women have a higher risk of preterm delivery than Caucasian women, and inflammatory stimuli affect gene expression in cells related to PCOS, showing a heightened inflammatory state in women with PCOS.